Abstracts tagged "guidelines and systemic lupus erythematosus (SLE)"

Abstract Number: 1599 • 2017 ACR/ARHP Annual Meeting
GRADE-Based Recommendations for the Diagnosis and Monitoring of Systemic Lupus Erythematosus in Canada
Stephanie Keeling¹, Zainab Alabdurubalnabi², J. Antonio Avina-Zubieta³, Susan Barr⁴, Louise Bergeron⁵, Sasha Bernatsky⁶, Josiane Bourré-Tessier⁷, Ann E. Clarke⁸, Alexandra Baril-Dionne⁹, Jan Dutz², Stephanie Ensworth¹⁰, Aurore Fifi-Mah¹¹, Paul R. Fortin¹², Dafna D Gladman¹³, Derek Haaland¹⁴, John G. Hanly¹⁵, Linda T Hiraki¹⁶, Sara Hussein⁹, Kimberly Legault¹⁷, Deborah M. Levy¹⁶, Lily Lim¹⁸, Mark Matsos¹⁹, Emily McDonald²⁰, Jorge Medina-Rosas²¹, Jordi Pardo Pardo²², Christine A. Peschken²³, Christian Pineau²⁴, Janet E. Pope²⁵, Tamara Rader²⁶, Jennifer Reynolds², Earl Silverman¹⁶, Manon Suitner⁹, Konstantinos Tselios²⁷, Murray Urowitz²⁸, Zahi Touma²⁹, Evelyne Vinet³⁰ and Nancy Santesso¹⁷, ¹Department of Medicine, University of Alberta, Division of Rheumatology, Edmonton, AB, Canada, ²Medicine, University of British Columbia, Vancouver, BC, Canada, ³Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada, ⁴Medicine, University of Calgary, Calgary, AB, Canada, ⁵Canadian Arthritis Patient Alliance, Toronto, ON, Canada, ⁶Divisions of Rheumatology and Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, QC, Canada, ⁷Rheumatology, University of Montreal, Montreal, QC, Canada, ⁸Division of Rheumatology, University of Calgary, Calgary, AB, Canada, ⁹Université de Montréal, Montreal, QC, Canada, ¹⁰University of British Columbia, Vancouver, BC, Canada, ¹¹University of Calgary, Calgary, AB, Canada, ¹²Medicine, CHU de Quebec - Universite de Laval, Quebec, QC, Canada, ¹³Centre for Prongosis Studies in The Rheumatic Diseases, Toronto Western Hospital, Krembil Research Institute, Toronto, ON, Canada, ¹⁴Rheumatology, Clinical Immunology & Allergy, McMaster University, Barrie, ON, Canada, ¹⁵Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, NS, Canada, ¹⁶Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ¹⁷McMaster University, Hamilton, ON, Canada, ¹⁸Hospital for Sick Children, Toronto, ON, Canada, ¹⁹Medicine, McMaster University, McMaster, ON, Canada, ²⁰Medicine, McGill University, Montreal, QC, Canada, ²¹Rheumatology, Universidad de la Sabana, Bogota, Colombia, ²²Centre for Practice Changing Research, Ottawa Hospital Research Institute, Ottawa, ON, Canada, ²³RR 149G, Univ of Manitoba, Winnipeg, MB, Canada, ²⁴Division of Rheumatology, McGill University Health Centre, Montreal, QC, Canada, ²⁵Department of Medicine, Division of Rheumatology, University of Western Ontario, St Joseph's Health Care, London, ON, Canada, ²⁶The Ottawa Hospital - General Campus, Trials Search Coordinator Knowledge Translation Specialist Cochrane Musculoskeletal Group Centre for Practice Changing Research, Ottawa, ON, Canada, ²⁷Medicine, University of Toronto, Toronto, ON, Canada, ²⁸Centre for Prognosis Studies in the Rheumatic Diseases, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ²⁹Rheumatology, University of Toronto, Division of Rheumatology, Institute of Health Policy, Management and Evaluation, Toronto, ON, Canada, ³⁰Divisions of Rheymatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada
Background/Purpose: To develop GRADE-based recommendations for the diagnosis and monitoring of systemic lupus erythematosus patients in Canada.Methods: Recommendations were developed using the GRADE (Grading of…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].